These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28923296)

  • 1. Malignant transformation of oral leukoplakia in a patient with dyskeratosis congenita.
    Bongiorno M; Rivard S; Hammer D; Kentosh J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Oct; 124(4):e239-e242. PubMed ID: 28923296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of the tongue in 5-year-old girl with dyskeratosis congenita.
    Jh K; Cs K
    Int J Oral Maxillofac Surg; 2021 Dec; 50(12):1546-1549. PubMed ID: 33736925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature.
    Treister N; Lehmann LE; Cherrick I; Guinan EC; Woo SB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Nov; 98(5):566-71. PubMed ID: 15529128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral carcinoma in a young man: a case of dyskeratosis congenita.
    Moretti S; Spallanzani A; Chiarugi A; Muscarella G; Battini ML
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):123-5. PubMed ID: 10972098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.
    Callea M; Martinelli D; Cammarata-Scalisi F; Grimaldi C; Jilani H; Grimaldi P; Willoughby CE; Morabito A
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyskeratosis congenita: oral hyperkeratosis in association with lichenoid reaction.
    Handley TP; Ogden GR
    J Oral Pathol Med; 2006 Sep; 35(8):508-12. PubMed ID: 16918603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma of the tongue in a patient with dyskeratosis congenita: a rare entity.
    Fatehi KS; Thiagarajan S; Dhar H; Chaukar D; DCruz AK
    Br J Oral Maxillofac Surg; 2019 Jan; 57(1):79-81. PubMed ID: 30587389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dyskeratosis congenita associated with leukoplakia of the tongue.
    Noto Z; Tomihara K; Furukawa K; Noguchi M
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid progression of an idiopathic leukoplakia to a proliferative verrucous leukoplakia lesion and then squamous cell carcinoma.
    Dal Vechio A; Nakagima E; Azevedo LH; Alves FA; Migliari DA
    Quintessence Int; 2012; 43(7):583-5. PubMed ID: 22670253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyskeratosis congenita with malignant transformation.
    Ray JG; Swain N; Ghosh R; Richa ; Pattanayak Mohanty S
    BMJ Case Rep; 2011 Jan; 2011():. PubMed ID: 22715219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentially Malignant Oral Disorders and Cancer Transformation.
    Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
    Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Angiosarcoma with Dyskeratosis Congenita.
    Horiguchi N; Kakizaki S; Iizuka K; Hagiwara S; Ohyama T; Yamazaki Y; Shibusawa N; Sato K; Kusano M; Nakazato Y; Yamada M
    Intern Med; 2015; 54(22):2867-72. PubMed ID: 26568000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskeratosis congenita: report of a case.
    Brown CJ
    Int J Paediatr Dent; 2000 Dec; 10(4):328-34. PubMed ID: 11310247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyskeratosis congenita: presentation of cutaneous triad in a sporadic case.
    Sharma RK; Gupta M; Sood S; Gupta A
    BMJ Case Rep; 2018 Nov; 11(1):. PubMed ID: 30567110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of oral leukoplakia with the CO2 laser: A retrospective study of 65 patients.
    Mogedas-Vegara A; Hueto-Madrid JA; Chimenos-Küstner E; Bescós-Atín C
    J Craniomaxillofac Surg; 2015 Jun; 43(5):677-81. PubMed ID: 25913630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita with portal hypertension of unknown etiology.
    Redkar NN; Pandey DB; Jerajani HR; Padhiyar R; Dhokare A
    J Assoc Physicians India; 2011 Apr; 59():260-3. PubMed ID: 21755768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.
    Saito T; Sugiura C; Hirai A; Notani K; Totsuka Y; Shindoh M; Fukuda H
    Int J Oral Maxillofac Surg; 2001 Feb; 30(1):49-53. PubMed ID: 11289621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases.
    Liu W; Shen XM; Liu Y; Li J; Zhou ZT; Wang LZ
    J Oral Pathol Med; 2011 Apr; 40(4):312-6. PubMed ID: 21342275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyskeratosis congenita: its connections with oral and maxillofacial surgery.
    Sabesan T; Baheerathan NN; Ilankovan V
    Br J Oral Maxillofac Surg; 2007 Mar; 45(2):156-8. PubMed ID: 16024141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.